NCT00384150 2015-11-26
Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL)
Biogen
Phase 3 Terminated
Clinical Trials
5 trialsNCT00363636 2015-10-02
A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)
Biogen
Phase 3 Terminated
NCT00048555 2013-09-16
Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma
Biogen
Phase 1/2 Completed
NCT00575068 2012-06-08
Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma
Biogen
Phase 1/2 Completed
NCT00651443 2011-01-07
Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's Lymphoma
Biogen
Phase 1 Terminated